Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan

• Status: Completed
• Trial end date: 2006-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Linezolid

Criteria

Inclusion Criteria:

• infection due to methicillin-resistant Staphylococcus aureus

Exclusion Criteria:

• hypersensitivity to linezolid